the Correlation Between Mark Color and Pain Relief of Cupping Therapy: a Cross-over Randomized Controlled Trial of 100 Patients with Fibromyalgia Syndrome

the Correlation Anlaysis Research of Constitution, Mark Color and Clinical Effectiveness Based on Regression Model

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100004712

Enrollment

Unknown

Registered

2021-04-08

Start date

2021-04-06

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia syndrome

Interventions

Cupping group:Null

Waiting list group :Null

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Participants who meet the diagnostic criteria for fibromyalgia syndrome formulated by the American Rheumatology Society. 2. Participants whose scores for pain intensity are more than 30mm (measured by Visual analogue score, VAS 0-100mm). 3. Participants aged 18-75 years. 4. Participants who fully understand the research process and are willing to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with mental disorders or other serious organic diseases, such as organ failure. 2. Patients with hyperemia or coagulation dysfunction. 3. Patients taking oral pain medication or undergoing other interventions for pain relief during the trial. 4. Pregnant or lactating women. 5. Patients currently participating in another clinical trial.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale;Cupping mark color scale;Hemodynamic parameters scale;	—

Secondary

Measure	Time frame
Adverse events;The consumption of analgesics;	—

Countries

China

Contacts

Public ContactCao Huijuan

huijuancao327@hotmail.com+86 13466615885

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026